Fish Oil Supplements Associated with Risk of Atrial Fibrillation
FDA Approves Relyvrio for ALS Treatment
How Digital Companions, Therapeutics Are Changing Healthcare
Pharmaceutical Company Biogen to Pay $900M False Claims Act Settlement
How Federal and State Laws Have Hindered Access to OUD Treatment
FDA Approved Psilocybin Investigational New Drug Application
Digital Health Tools Are Perceived as an Advantage to 93% of Physicians
US FDA Accelerated Approval for 48 Non-oncology Drugs
Walgreens’ $1.67-Billion Specialty Pharmacy and Home Health Play
How a New Antiviral Therapy May Prevent COVID-19 Transmission
McKesson Plans to Acquire Rx Savings Solutions
Pregnant and Lactating Individuals Tolerate COVID Vaccine Boosters
FDA and NIH Launch Partnership for Rare Neurodegenerative Diseases
Amgen’s Immunotherapy for Lung Cancer Reduces Disease Progression by 34%
Biden Administration Appoints Renee Wegrzyn as Director of the ARPA-H
Medications in the US Are More Widely Available than in Germany
Democratizing Access to Clinical Trials through Remote Patient Monitoring
Psilocybin-Assisted Psychotherapy Reduces Heavy Drinking
Glucocorticoids Alter Brain Volume and White Matter Microstructure
Federal Judge Rules against Mandated HIV PrEP Coverage
Paxlovid Advantageous for Elderly COVID-19 Patients, Ineffective in Younger Adults
Stroke Prevention Study to Analyze Benefits of Wearable Devices
FDA Announces That 35% of Drug Samples Were Non-Compliant
FDA Approves Bivalent COVID Boosters
FDA Approved the Use of Omnipod 5 for Children Over 2